Paul Edward Walker's Net Worth

$1.04 Thousand

Estimate Recalculated Nov 1, 2024 06:31AM EST

Who is Paul Edward Walker?

Paul Edward Walker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TESARO, Inc., Allakos Inc., NeueHealth, Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Metacrine, Inc., Trillium Therapeutics Inc., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Marker Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., Regulus Therapeutics Inc., and Korro Bio, Inc..

SEC CIK

Paul Edward Walker's CIK is 0001553150

Past Insider Trading and Trends

2013 was Paul Edward Walker's most active year for acquiring shares with 2 total transactions. Paul Edward Walker's most active month to acquire stocks was the month of May. 2021 was Paul Edward Walker's most active year for disposing of shares, totalling 1 transactions. Paul Edward Walker's most active month to dispose stocks was the month of October. 2022 saw Paul Edward Walker paying a total of $0.00 for 99,590 shares, this is the most they've acquired in one year. In 2021 Paul Edward Walker cashed out on 40,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TESARO, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.38%
94
—
—
4.04K
Jun 2
Form 4
+31.74%
951
—
—
3.95K
Jun 3
Form 4
∞
3K
—
—
3K
Oct 15
Form 3
—
0
—
—
0
No matching records found

Allakos Inc. (ALLK) Snapshot price: $0.648

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 24
Form 4
—
0
—
—
0
May 25
Form 4
+184.17%
3.98M
$5.02
$19,999,680.00
6.15M
Sep 21
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 25
Form 4
-4.56%
-103.42K
$141.29
-$14,611,230.54
2.16M
Dec 30 - Dec 31
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
Jun 6
Form 3
—
0
—
—
0
No matching records found

NeueHealth, Inc. (BHG) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 8
Form 4
—
0
—
—
0
Dec 19
Form 4
—
0
—
—
0
Oct 31
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Aug 11
Form 4
—
0
—
—
0
Oct 17
Form 4
—
0
—
—
0
Jan 3
Form 4
∞
71.91M
$18.00
—
71.91M
Jun 28
Form 3
—
0
—
—
0
No matching records found

Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $5.69

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
7.69M
$19.00
—
7.69M
Jun 28
Form 3
—
0
—
—
0
No matching records found

Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $41.12

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-47.77%
-2.00M
—
—
2.19M
Jun 13
Form 4
∞
4.19M
$15.00
—
4.19M
Jul 22
Form 3
—
0
—
—
0
No matching records found